Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.55    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.048 (8.696%)
Market Cap: £3.20m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Futura Medical News

Futura Medical surges on EU approval for topical erection gel
30 Apr 2021

Futura Medical surges on EU approval for topical erection gel

(Sharecast News) - Pharmaceutical company Futura Medical has received CE marking for its 'MED3000' erectile dysfunction gel, it announced on Friday.

Futura wins EU approval for "breakthrough" erectile dysfunction gel
30 Apr 2021

Futura wins EU approval for "breakthrough" erectile dysfunction gel

Futura wins EU approval for "breakthrough" erectile dysfunction gel

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"
30 Apr 2021

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

TRADING UPDATES: HSBC announces redemption of US dollar securities
15 Apr 2021

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: Quixant swings to 2020 loss but recommends dividend
14 Apr 2021

TRADING UPDATES: Quixant swings to 2020 loss but recommends dividend

TRADING UPDATES: Quixant swings to 2020 loss but recommends dividend

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
22 Mar 2021

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

Futura Medical shares rise on FDA's agreement for MED3000 study
22 Mar 2021

Futura Medical shares rise on FDA's agreement for MED3000 study

Futura Medical shares rise on FDA's agreement for MED3000 study

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral
22 Mar 2021

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral